EUVIMEDEUVIMED entdecken
Crossref

Neurobiological architecture of first-episode, drug-naive late-life depression: Insights from multimodal MRI, transcriptomics, and neurotransmitter mapping

Heng Shao, Xiaohui Yu, Yan Zhang, Yingjie Yang, Jiaojian Wang, Chengsi Luo, Jie Zhang

Journal of Affective Disorders · 2026-07 · 405 · 121532

DOI: 10.1016/j.jad.2026.121532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2026-07. Verfasst von Heng Shao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First People's Hospital of Yunnan Province, Kunming University of Science and Technology Affiliated Hospital, Kunming, …. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Transcriptome, Brain, Neurotransmitter Agents. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Kunming University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE To elucidate the neurobiological architecture of late-life depression (LLD) by integrating macroscopic multimodal MRI with microscopic transcriptomic and neurochemical mapping. METHODS We analyzed 39 first-episode, drug-naive LLD patients and 41 matched healthy controls (HC) using structural MRI, diffusion kurtosis imaging, and resting-state fMRI. Data were processed to extract gray matter volume (GMV), white matter diffusion metrics (FA, MD, AD, RD), and functional indices (fALFF, DC), with group differences evaluated under rigorous multiple-comparison corrections. To elucidate molecular underpinnings, partial least squares (PLS) regression was applied to link neuroimaging t-maps with Allen Human Brain Atlas gene expression profiles. Spatial correlations between neuroimaging statistical maps and PET-derived neurotransmitter receptor density maps were further examined to identify neurochemical substrates. RESULTS LLD patients exhibited localized gray matter volume (GMV) reductions in the right fusiform gyrus and limbic structures, widespread microstructural white matter degradation across fronto-limbic tracts, and increased functional amplitude and network centrality centered on the medial prefrontal cortex (mPFC). Transcriptomic decoding linked these macroscopic anomalies to gene sets enriched for mitochondrial metabolism, calcium signaling, and synaptic organization. Furthermore, spatial correlation analyses uniquely revealed that structural atrophy was predominantly associated with the glutamatergic system, whereas functional and network alterations aligned most robustly with the opioid system. CONCLUSIONS Our findings support a multi-scale neurobiological model of LLD, wherein distinct molecular deficits in bioenergetics, glutamatergic excitotoxicity, and opioid neurotransmission underlie macroscopic structural and functional network failures. This integrative framework identifies specific neurochemical systems as prime mechanistic substrates and potential therapeutic targets for the cognitive-emotional dysregulation characteristic of LLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingTranscriptomeBrainNeurotransmitter AgentsMajor Depressive DisorderHumansFemaleMaleGray MatterWhite MatterMiddle AgedMultimodal ImagingAgedBrain MappingPositron-Emission TomographyReceptors, NeurotransmitterDiffusion Tensor ImagingPrefrontal CortexCase-Control Studies

Stichwörter der Autor:innen

Drug-naiveImaging transcriptomicsLate-life depressionMultimodal MRINeurotransmitter receptors

Substanzen

Neurotransmitter AgentsReceptors, Neurotransmitter

Autor:innen und Institutionen

  • Department of Geriatrics, The First People's Hospital of Yunnan Province, Kunming University of Science and Technology Affiliated Hospital, Kunming, China.
  • State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, China; Yunnan Key Laboratory of Primate Biomedical Research, Kunmi…
  • Department of MRI, The First People's Hospital of Yunnan Province, Kunming University of Science and Technology Affiliated Hospital, Kunming, China.
  • Second Department of Neurosurgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Department of MRI, The First People's Hospital of Yunnan Province, Kunming University of Science and Technology Affiliated Hospital, Kunming, China. Electronic address: 13808709420m@sina.cn.

Förderung

  • Kunming University of Science and Technology

Zitieren

APA

Shao, H., Yu, X., Zhang, Y., Yang, Y., Wang, J., Luo, C., & Zhang, J. (2026). Neurobiological architecture of first-episode, drug-naive late-life depression: Insights from multimodal MRI, transcriptomics, and neurotransmitter mapping. Journal of Affective Disorders, 405, 121532. https://doi.org/10.1016/j.jad.2026.121532

Vancouver

Shao H, Yu X, Zhang Y, Yang Y, Wang J, Luo C, et al. Neurobiological architecture of first-episode, drug-naive late-life depression: Insights from multimodal MRI, transcriptomics, and neurotransmitter mapping. Journal of Affective Disorders. 2026;405:121532. doi:10.1016/j.jad.2026.121532

BibTeX
@article{Shao2026,
  author = {Shao, Heng and Yu, Xiaohui and Zhang, Yan and Yang, Yingjie and Wang, Jiaojian and Luo, Chengsi and Zhang, Jie},
  title = {Neurobiological architecture of first-episode, drug-naive late-life depression: Insights from multimodal MRI, transcriptomics, and neurotransmitter mapping},
  journal = {Journal of Affective Disorders},
  year = {2026},
  volume = {405},
  pages = {121532},
  doi = {10.1016/j.jad.2026.121532}
}
Kostenlos starten →